A detailed history of Oracle Alpha Inc. transactions in Organon & Co. stock. As of the latest transaction made, Oracle Alpha Inc. holds 15,371 shares of OGN stock, worth $229,796. This represents 0.52% of its overall portfolio holdings.

Number of Shares
15,371
Previous 13,833 11.12%
Holding current value
$229,796
Previous $199 Million 44.87%
% of portfolio
0.52%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $21,193 - $28,914
1,538 Added 11.12%
15,371 $289 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $151,471 - $239,587
13,833 New
13,833 $199 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.8B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.